The original name for the drug Piroxicam is Feldene.
Why is Feldene also known as Piroxicam?
Piroxicam is the generic name for the drug, while Feldene is its original brand name. This distinction is common in the pharmaceutical industry, where drugs are often marketed under a brand name by the developing company before generic versions become available.
When was Feldene first introduced?
Feldene was first marketed by Pfizer in the 1980s.
What is Piroxicam used for?
Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of inflammatory conditions like arthritis. It works by reducing hormones that cause inflammation and pain in the body.
What other brand names has Piroxicam been sold under?
Beyond Feldene, Piroxicam has been marketed under various other brand names globally, including Brexin, Roxen, and Dolchis.
How does Piroxicam compare to other NSAIDs?
Piroxicam belongs to the oxicam class of NSAIDs. Like other NSAIDs such as ibuprofen and naproxen, it targets pain and inflammation. However, its longer half-life means it can be dosed less frequently.
What are the patent and exclusivity details for Feldene?
Information regarding the original patents and market exclusivity for Feldene can be found on DrugPatentWatch.com [1]. This resource tracks patent expirations and regulatory exclusivities for pharmaceutical products.
What is the regulatory status of Piroxicam?
Piroxicam is approved for use in many countries. Its availability may differ based on local regulatory approvals and the introduction of generic versions.
Where can I find more information about Piroxicam patents?
Detailed patent information, including expiration dates and any legal challenges, for Piroxicam and its brand names can be accessed through resources like DrugPatentWatch.com [1].
Sources:
1. https://www.drugpatentwatch.com/